GetTopicDetailResponse(id=8c9b38898c5, topicName=吉妥珠單抗, introduction=吉妥珠單抗, content=null, image=null, comments=3, allHits=1097, url=https://h5.medsci.cn/topic?id=38898, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=47183, tagList=[TagDto(tagId=47183, tagName=吉妥珠單抗)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2046408, encodeId=f6642046408a9, content=<a href='/topic/show?id=8c9b38898c5' target=_blank style='color:#2F92EE;'>#吉妥珠單抗#</a>, objectTitle=Front Immunol：吉妥珠單抗奧佐米星治療各種亞組急性髓系白血病的臨床益處和安全性，一項(xiàng)更新的系統(tǒng)評(píng)價(jià)、meta分析和網(wǎng)絡(luò)meta分析, objectType=article, longId=294663, objectId=c3e2294663d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3e2294663d3, replyNumber=0, likeNumber=94, createdTime=2022-09-13, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3e2294663d3, moduleTitle=Front Immunol：吉妥珠單抗奧佐米星治療各種亞組急性髓系白血病的臨床益處和安全性，一項(xiàng)更新的系統(tǒng)評(píng)價(jià)、meta分析和網(wǎng)絡(luò)meta分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c3e2294663d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2046407, encodeId=cadb204640eb4, content=<a href='/topic/show?id=8c9b38898c5' target=_blank style='color:#2F92EE;'>#吉妥珠單抗#</a>, objectTitle=Blood：標(biāo)準(zhǔn)化療聯(lián)合吉妥珠單抗治療AML, objectType=article, longId=185544, objectId=a879185544c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a879185544c4, replyNumber=0, likeNumber=92, createdTime=2020-06-08, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a879185544c4, moduleTitle=Blood：標(biāo)準(zhǔn)化療聯(lián)合吉妥珠單抗治療AML, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a879185544c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2046406, encodeId=3e95204640639, content=<a href='/topic/show?id=8c9b38898c5' target=_blank style='color:#2F92EE;'>#吉妥珠單抗#</a>, objectTitle=Blood: 5年長(zhǎng)期聯(lián)合使用全反式視黃酸+三氧化砷+吉妥珠單抗藥物治療急性早幼粒細(xì)胞白血病的跟蹤報(bào)道, objectType=article, longId=91764, objectId=6f1891e6454, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f1891e6454, replyNumber=0, likeNumber=90, createdTime=2017-09-23, rootId=0, userName=lixiao3326, userId=d39f177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f1891e6454, moduleTitle=Blood: 5年長(zhǎng)期聯(lián)合使用全反式視黃酸+三氧化砷+吉妥珠單抗藥物治療急性早幼粒細(xì)胞白血病的跟蹤報(bào)道, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6f1891e6454)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話(huà)題小助手
2020-05-29
